• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Brain+

Less than 1K followers
Overview
Investor consensus
All
Press releases
3rd party
ShowingAll content types

Regulatory press release2026-03-23 13:36

Bankruptcy order issued for BRAIN+ A/S

Brain+
Regulatory press release2026-03-19 13:59

BRAIN+ A/S to file for bankruptcy - 19 March 2026

Brain+
Regulatory press release2026-03-12 15:12

Update on in-court restructuring proceedings - 12 March 2026

Brain+

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-03-05 13:20

Update on in-court restructuring proceedings - 5 March 2026

Brain+
Regulatory press release2026-02-13 16:34

Update on in-court restructuring proceedings - 13 February 2026

Brain+
Regulatory press release2026-02-04 17:36

Update on in-court restructuring proceedings - 4 February 2026

Brain+
Regulatory press release2026-01-27 13:34

Correction: Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release2026-01-27 13:10

Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release2026-01-20 20:52

Notice of in-court restructuring proceedings of BRAIN+ A/S

Brain+
Regulatory press release2026-01-20 10:07

Brain+ is seeking restructuring proceedings

Brain+
Press release2026-01-08 22:29

Brain+ Investor Update – December 2025

Brain+
Press release2025-12-04 12:46

Brain+ Investor Update - November

Brain+
Press release2025-11-21 15:15

Impala Nordic: Brain+ - Guidance cut as timing delays intensify

Brain+
Regulatory press release2025-11-19 12:24

Brain+ A/S updates its financial guidance for 2025

Brain+
Press release2025-11-06 15:13

Brain+ investor update — October

Brain+
Press release2025-10-31 08:00

BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE

Brain+
Regulatory press release2025-10-06 08:20

Brain+ appoints new Chief Financial Officer

Brain+
Press release2025-09-24 15:40

Impala Nordic: Brain+ – First Ayla NHS pilot launch in UK primary care

Brain+
Press release2025-09-24 08:36

Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices

Brain+
Press release2025-09-16 09:21

Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla

Brain+